Veterinary Medicine Information website

Metrobactin 500 mg tablets for cats and dogs

Authorised
  • Metronidazole
Download as PDF

Product identification

Medicine name:
Metrobactin 500 mg tablets for cats and dogs
Active substance:
  • Metronidazole
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Metronidazole
    500.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • Aluminium - PVC/PE/PVDC blister. Cardboard box containing 10 boxes, each containing 10 blisters of 10 tablets.
  • Aluminium - PVC/PE/PVDC blister. Cardboard box containing 10 boxes, each containing 1 blister of 10 tablets.
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 5 blisters of 10 tablets
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 7 blisters of 10 tablets
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 6 blisters of 10 tablets
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 50 blisters of 10 tablets
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 1 blister of 10 tablets
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 9 blisters of 10 tablets
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 8 blisters of 10 tablets
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 10 blisters of 10 tablets
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 4 blisters of 10 tablets
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 3 blisters of 10 tablets
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 25 blisters of 10 tablets
  • Aluminium - PVC/PE/PVDC blister. Cardboard box of 2 blister of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
  • Lelypharma B.V.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 55019
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0193/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (, TABLETTER 250 MG OG 500 MG)
Published on: 14/03/2026
Download